Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald F Smee

Showing results (51-60 of 123) with videos related to

Pageof 13
Sort By:
Antiviral Research|August 14, 2020
Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virusJustin G Julander, Ashley Dagley, Makda Gebre, et al.
European Journal of Medicinal Chemistry|July 2, 2013
Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinonesDmytro Havrylyuk, Borys Zimenkovsky, Olexandr Vasylenko, et al.
Antiviral Research|February 5, 2009
A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assaysJason P Roth, Joseph K-K Li, Donald F Smee, et al.
Antiviral Research|March 21, 2012
Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in miceE Bart Tarbet, Masako Maekawa, Yousuke Furuta, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2006
Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotypeRichard S Kornbluth, Donald F Smee, Robert W Sidwell, et al.
Antiviral Research|July 31, 2007
Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virusDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Chemistry & Chemotherapy|July 12, 2005
Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in miceDonald F Smee, Miles K Wandersee, Kevin W Bailey, et al.
Antiviral Research|March 29, 2011
Evaluation of imiquimod for topical treatment of vaccinia virus cutaneous infections in immunosuppressed hairless miceE Bart Tarbet, Deanna Larson, Bentley J Anderson, et al.
Antiviral Research|October 31, 2009
Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease modelsBrian B Gowen, Min-Hui Wong, Kie-Hoon Jung, et al.
Plos Neglected Tropical Diseases|October 25, 2011
Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic FeverMichelle Mendenhall, Andrew Russell, Donald F Smee, et al.
Pageof 13

Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Antiviral Research|August 14, 2020
Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virusJustin G Julander, Ashley Dagley, Makda Gebre, et al.
European Journal of Medicinal Chemistry|July 2, 2013
Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinonesDmytro Havrylyuk, Borys Zimenkovsky, Olexandr Vasylenko, et al.
Antiviral Research|February 5, 2009
A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assaysJason P Roth, Joseph K-K Li, Donald F Smee, et al.
Antiviral Research|March 21, 2012
Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in miceE Bart Tarbet, Masako Maekawa, Yousuke Furuta, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2006
Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotypeRichard S Kornbluth, Donald F Smee, Robert W Sidwell, et al.
Antiviral Research|July 31, 2007
Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virusDonald F Smee, Brett L Hurst, Min-Hui Wong, et al.
Antiviral Chemistry & Chemotherapy|July 12, 2005
Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in miceDonald F Smee, Miles K Wandersee, Kevin W Bailey, et al.
Antiviral Research|March 29, 2011
Evaluation of imiquimod for topical treatment of vaccinia virus cutaneous infections in immunosuppressed hairless miceE Bart Tarbet, Deanna Larson, Bentley J Anderson, et al.
Antiviral Research|October 31, 2009
Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease modelsBrian B Gowen, Min-Hui Wong, Kie-Hoon Jung, et al.
Plos Neglected Tropical Diseases|October 25, 2011
Effective oral favipiravir (T-705) therapy initiated after the onset of clinical disease in a model of arenavirus hemorrhagic FeverMichelle Mendenhall, Andrew Russell, Donald F Smee, et al.
Pageof 13